← Open Payments lookup

KEVIN ROA: Open Payments

NPI 1609597392 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,411 in 148 payments from 15 companies in 2025. Trend: 2023 $808 · 2024 $1,754 · 2025 $3,411

Food & beverage: $3,301Education: $109
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.33$741
Neurocrine BioSciences, Inc.19$503
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$368
Alkermes, Inc.13$356
E.R. Squibb & Sons, L.L.C.21$339
Teva Pharmaceuticals USA, Inc.9$258
Vanda Pharmaceuticals Inc.8$246
ABBVIE INC.7$220
Janssen Pharmaceuticals, Inc5$108
Axsome Therapeutics, Inc.3$66

Products named: REXULTI, INGREZZA, CAPLYTA, ARISTADA, COBENFY, FANAPT, VRAYLAR, ABILIFY MAINTENA.

Industry payments across NV — which companies pay providers there.